Abstract Building research infrastructure capacity to address clinical and translational gaps has been a focus of funding agencies and foundations. Clinical and Translational Sciences Awards, Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR), and the Institutional Development Award Infrastructure for Clinical and Translational Research funded by the US government to fund clinical translational research programs have existed for over a decade to address racial and ethnic health disparities across the USA. While the impact on the nation's health cannot be made in a short period, assessment of a program's impact could be a litmus test to gauge its effectiveness at the institution and communities. We report the success of a Pilot Project Program in the University of Hawaii RCTR Award in advancing careers of emerging investigators and community collaborators. Our findings demonstrated that the investment has a far-reaching impact on engagement with community-based research collaborators, career advancement of health disparity investigators, and favorable impacts on health policy.
Introduction
Health inequities continue to persist in communities across the disease spectrum throughout the USA and globally [1] [2] [3] . Contributing to the culture of health disparities has partly been a function of the imbalance of biomedical research funding from government agencies, private foundations, industry, and other sources [4] [5] [6] [7] . Innovative concepts and bold initiatives to increase collaborations and partnerships were established through government, industry, and foundations to increase translation of research into practice to accelerate medical research [6] [7] [8] [9] [10] . Concepts and ideas to increase capacity to address clinical and translational gaps in the health of the population included new approaches to discovery, developing partnerships between government and private sectors, identifying research teams, and redesigning the clinical research paradigm [6, 10] . A number of research initiatives were instituted by various funding agencies to address clinical and translational gaps to bring entities together to accelerate the pace of discovery, from the earliest discovery stages through clinical research [11] [12] [13] [14] [15] [16] [17] . What followed in the USA, among many other infrastructure programs, were the Clinical and Translational Sciences Award (CTSA) program funded by the National Center for Advancing Translational Sciences (NCATS) [18, 19] , Research Centers in Minority Institutions (RCMI) Infrastructure for Clinical and Translational Research (RCTR) funded by National Institute of Minority Health and Health Disparities (NIMHD) [20] , and the Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR) funded by National Institute of General Medical Sciences (NIGMS) ( Table 1 ).
Recognizing that building capacity to engage in clinical translational research at institutions across the USA requires collaborations and partnerships, the CTSA mechanism was launched to support programs and infrastructures for translational science [7, 19] . The success of the CTSA programs impacted geographical regions based at the institutions involved with their respective CTSA programs [21] [22] [23] [24] [25] . On a smaller scale and owing to the limitations placed by the NIH IDeA program, institutions from IDeA-eligible states developed clinical and translational research capacity at their institutions beginning in 2014 [26] . In a similar fashion, RCMI institutions were provided opportunities to develop infrastructures to conduct clinical and translational research [11] [12] [13] [14] [15] [16] [17] . The University of Hawaii (UH), as an RCMI institution, established the RCMI Multidisciplinary and Translational Research Infrastructure Expansion (RMATRIX) program as an RCTR which has grown to be a successful clinical and translational research foundation for faculty members at UH [20] . Nationally, millions of federal and foundation dollars have been invested into these and other clinical and translational research infrastructure programs. We report the success of a Pilot Project Program of RMATRIX at UH which not only built research capacity locally but also impacted clinical and translational research far beyond Hawaii through the support of academic investigators with Pilot Project Awards. One of unique characteristics of Hawaii was that as the 50th state of the USA, its geographical isolation in the Pacific Ocean distinguished it as having the only accredited USA medical school within a 2400-mile radius. With its diverse ethnic population including Native Hawaiians, Pacific Islanders, Asians, and Filipinos, the RMATRIX program at UH was uniquely situated with its infrastructure to potentially contribute to the clinical translational landscape in Hawaii to benefit its population. One component of the RMATRIX program was the Pilot Project Program which provided resources and funds for emerging investigators to support research projects focusing on health inequities in the communities. We report that the investment not only built the clinical and translational research infrastructure at UH but the dollars had a far-reaching impact that connected communities and collaborators both locally and nationally where health inequities also persisted.
Methods

RMATRIX Program
The Institutional Review Board (IRB) of the UH Human Studies Program reviewed the principle of the project. The In the successful renewal application, lessons learned allowed the program to focus on three HEALTH Initiatives which resonated with the communities and investigators through needs assessments: nutrition and metabolic health, reproductive growth and developmental health, and aging and chronic disease prevention/management.
While RMATRIX supported investigators interested in clinical and translational research across the spectrum of the HEALTH Initiatives, this report will highlight the continuing activities of investigators from the first 3 years of the RMATRIX Pilot Project Program. Data from 3 to 5 years after the pilot projects were awarded provided facts and figures on the ongoing impact of the RMATRIX program which informed this report.
RMATRIX Pilot Project Program
The Pilot Project Program promoted inter-professional translational research in health disparities by supporting research endeavors and collaborations among emerging investigators. The Pilot Project Program released an annual institution-wide request for proposals which encouraged multiple principal investigators and/or collaborators across disciplines. Presentations at department and school faculty meetings were also held to disseminate information about the funding opportunities. Direct costs up to $30,000 per year for 1-year projects were allowed, with priority given to those studies which focused on one of the HEALTH Initiatives. From 2010 to 2012, 18 pilot project investigators were awarded from 55 pilot project applications which were submitted in response to the RFP. At the time of the RFP release, webinars were held to guide and provide potential applicants information on the pilot project application process. Each cycle of applications underwent external review with at least two experienced external reviewers assigned to each application and scored similarly to the current NIH extramural grant review guidelines [27] . The level of funding available in 2010-2012 determined the number of Pilot Project Awards which were provided in each year: three awards to three investigators in 2010, eight awards to eight investigators in 2011, and six awards to seven investigators in 2012. The pilot project investigators' disciplines and pilot project titles are summarized in Table 2 .
RMATRIX Pilot Project Program Evaluation
The RMATRIX evaluators (from the second funding cycle) consisted of one MD and one MA/MPH with over 30 years each in health research including federal funding on multiyear grants and contracts as well as infrastructure development grants in minority health involving academia, medical centers, and community organizations throughout Hawaii. The evaluators were from an independent, nonprofit organization with research backgrounds who were each funded by grants and contracts and each understanding challenges that researchers faced. They employed qualitative methodology by using semi-structured interviews to collect information on pilot project investigators' perspectives and experiences. The semistructured interview process permitted maximum use of face-to-face time with each pilot project investigator. Interviews were conducted at a location selected by the pilot project investigator, usually a conference room at their department or in their office at the University or Medical Center.
Data were collected beginning 1 year after each pilot project investigator was awarded the RMATRIX Pilot Award through December 2015. RMATRIX Pilot Project investigators received their awards in 2010, 2011, and 2012, providing 3 to 5 years of follow-up data for analysis. A standardized list of outcomes was used to guide the interview process while not restricting the pilot project investigator from sharing additional information he/she felt important. This included publications; presentations; patents; further research after pilot award; continuation of pilot or new research; research role; awards/recognitions; promotions; job/career change; research findings that brought change to clinical or social service practice, resulted in change in organizational, local, state, or federal policies; findings used in advocacy; collaborators; disciplines; community involvement; and federal contacts (Table 3) . A copy of the outcomes to be discussed as well as evaluation questions were sent to all pilot project investigators before their interview. Each pilot project investigator was requested to send an updated resume to the evaluators prior to the in-person meeting. This allowed the evaluators to review the resume, note outcomes, and identify additional questions for the meeting. This helped to maximize the interview process and keep the total interview time to 1 h. The academic professional outcomes and measurements were reported based on the interview information of the pilot project investigators (Table 3) .
Results
Eighteen pilot project investigators received 17 pilot awards from 2010 to 2012 in RMATRIX. Seventeen of eighteen investigators in RMATRIX were contacted; however, the lack of contact information for the last investigator prevented followup. Fifteen investigators provided updated resumes and met with the evaluators. One pilot project investigator provided a resume but elected to not participate in the interview, while a second who moved to the mainland USA furnished an updated resume and answered the evaluation questions via email. The data presented summarize information from 17 investigators based on self-report and public documentation. The academic demographics of the investigators represented diverse disciplines across the spectrum and academic ranks (Table 4) .
Scholarly Assessment
Scholarly assessment was measured by the publications, presentations at scientific meetings and by funded grants. The successful achievements of the pilot project investigators were highlighted by publications in peer-reviewed journals and books since receiving their pilot awards as well as their contributions at scientific meetings with presentations (Table 4) . Since the completion of their pilot project, the 17 investigators had 47 grants which were currently active at the time of this report. An additional 34 grants were funded and completed since their pilot projects. In addition to the funding agencies noted in Table 2 , private foundations and pharmaceutical companies also contributed as sources. The 81 grants contributed over $79.5 million in research with each of the 17 investigators being principal investigators (PIs) on 60 grants which totaled $22.4 million in direct award dollars. The litmus test for RMATRIX investigators' research successes was based on being awarded federally funded grants [4] .
Professional Academic Assessment
Pilot project investigators were assessed on their academic achievements since being awarded the pilot project funds including promotions and new academic appointments (Table 4) .
Entrepreneurship Assessment
Entrepreneurship achievements were assessed by successful business ventures or related enterprises (Table 3) . Three investigators developed new startup companies based on their research and contributions from their pilot project data. These startup companies are employing graduates from UH, providing them with jobs in Hawaii in their discipline. Three patents were received, and four intellectual property agreements were filed.
Training the Next Generation of Faculty Researchers Assessment
Career development of faculty includes developing skills and ability to train emerging investigators and students to contribute to the pipeline of new clinical translational research faculty (Table 3) . To accomplish this, continued collaborations with other investigators contribute to the foundation. All of the pilot project investigators continued collaborations from their RMATRIX pilot work. Additionally, they have all become mentors themselves for students and other faculty. In 2015 alone, the 17 investigators have mentored 159 mentees including medical students, MDs, Master candidates, PhD candidates, PhDs, and undergraduate students.
Awards/Honors Assessment
Recognition of the accomplishments as a direct or indirect result of the Pilot Project Awards can contribute to clinical translation research through additional funding opportunities and scientific opportunities (Table 3) 
Scientific Impact Assessment
The scientific impact of the pilot project and/or contribution by the investigator was assessed by how the knowledge gained or results contributed to the health of the communities (Table 3) . Because of Hawaii's unique geographic location and diverse population, there are rich opportunities to examine how the environment, race and ethnicity, and culture impact the access, delivery, and outcomes of care and contribute to the significant health inequities identified among Native Hawaiians and Other Pacific Islanders. The potential scientific impact that the awarded pilot projects proposed was viewed positively by the external reviewers. As such, the success of the pilot projects provided scientific contributions across a wide spectrum including (1) physiological radar technology for sleep monitoring, (2) behavioral modification to reduce health disparities and chronic disease in Native Hawaiians and other high risk populations, (3) neuroimaging technique targeting monocytes for brain inflammation, (4) Properties of pulmonary surfactant in premature infants, (5) patent award and product development of a compound to effectively treat box jellyfish stings, and (6) patent on methods for prevention of cardiac hypertrophy.
Advocacy Assessment
The litmus test for effective clinical and translational research that impacts the population in Hawaii is policy and advocacy (Table 3) . RMATRIX Pilot Project investigators reported the following actions: (1) Hawaii State Senate Resolution to convene Native Hawaiian Health Task Force addressing health inequities, (2) establishment of Hawaii State Stroke Registry, and (3) disparity findings used for advocacy by community leaders and health professionals locally, nationally, and internationally.
Synergy and Collaborations Assessment
Establishing synergy and collaborations between the pilot project investigator and other leaders locally, nationally, and internationally has the potential to increase the impact that the research has on the population health in Hawaii as well as beyond the state (Table 3 ). The creation and launching of a new interdisciplinary translational class at UH combining engineering and pediatrics was one of the first of its kind at the institution. A statewide effort involving communities, health professionals, and academia united to support healthy choices to address obesity with launch of a successful program weight control program for children and families. The synergy and collaboration between engineering investigators working alongside health professionals to apply radar for sleep monitoring in the medical center bridged the engineering and medical disciplines in a positive and successful effort. Collaborations among academia, communities, and industry from local, national, and international regions are summarized in Fig. 1 which also shows the direct connections of the collaborators from other geographical regions of the world.
Discussion
The RMATRIX Pilot Project Program successfully launched and expanded clinical translational research opportunities for the emerging faculty who were instrumental in leveraging the resources and their pilot project data to benefit the institution and state. In addition to enhancing their respective academic careers, their efforts contributed to policies and launched collaborations to start new ventures and projects to potentially benefit the populations in Hawaii and expand beyond the state. At its inception, RMATRIX was conceived and envisioned to be a catalyst to build a critical mass of investigators who would conduct translational and clinical research in the HEALTH Initiatives that disproportionately affect Native Hawaiian and other Pacific Peoples in Hawaii. For many clinical and translational research infrastructure programs in the USA, a similar theme purveys to benefit the populations they serve or with whom they engage in their activities [4, 6, 7, 16-18, 20, 23, 26, 28] . While the long-term goal of promoting and improving health equity across all stages of life for the most disparate populations (by contributing to improving the health of all people in Hawaii) is an ambitious undertaking and not quickly attainable in a short period of time (3 years), the RMATRIX has put in place a valuable infrastructure for academic and community investigators to work together on approaches for the prevention, diagnosis, and treatment of diseases to improve health and reduce health disparities. RMATRIX is committed to further expanding and strengthening the infrastructure to lead by its success. Ultimately, the next steps for RMATRIX will be to demonstrate its success in improving health equities for the population in Hawaii.
RMATRIX has demonstrated the importance of career development and mentorship through the building of a critical mass of investigators committed to eliminating health inequities through clinical and translational health disparity research and collaborations with other institutions and communities as well as various professional disciplines locally, nationally, and internationally. With the large number of clinical and translational research infrastructure awards in existence [7, 12, 14, 16, 17, 24, 26, 29, 30] , RMATRIX is likely not unique in its impact or importance to the institution, state, or communities. Other successful infrastructure programs have pilot project mechanisms to jumpstart research careers of faculty [28, 30] ; however, because of the uniqueness of its size, location, and modest landscape in clinical and translational research at the UH, the magnitude of its impact may be more pronounced. As one of our pilot investigators noted, RMATRIX changed the intellectual atmosphere at UH and JABSOM, raising awareness of ethnic disparities in health, work that is supported by funding agencies, and bringing local indigenous investigators together with other groups nationally and internationally providing an avenue for new research. This successful program demonstrated how support for clinical and translational research could be leveraged and could set the cornerstone for similar programs to collaborate to ultimately benefit the health and well-being of the populations.
It has taken decades to recognize and acknowledge health inequities in our communities. Addressing these issues now using the mechanism of successful clinical and translational research infrastructure programs will help communities move from identification of the causes of health inequities toward the training of investigators with strong community partners who will develop effective interventions with strong scientific support that will lead to commercial products, changes in health professional practice, and well-grounded health policy that can turn the tide of health disparities affecting the population.
